EOLS Competitors & Alternatives

Compare Evolus Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

EOLS

Main Stock
$6.50
Tradestie Score
54
Market Cap
$397.82M
Revenue Growth
0.1%
Analyst Upside
+125.6%

Top Competitors

48 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
CRON Cronos Group Inc. Common Share
$2.63
$1.02B - 56 Compare
ANAB AnaptysBio, Inc. Common Stock
$63.15
$894.30M - 60 Compare
AQST Aquestive Therapeutics, Inc. Common Stock
$4.17
$711.32M - 65 Compare
KALV KalVista Pharmaceuticals, Inc. Common Stock
$26.73
$608.81M - 62 Compare
ESPR Esperion Therapeutics, Inc.
$3.12
$584.71M - 61 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$30.26
$543.32M - 61 Compare
SLDB Solid Biosciences Inc. Common Stock
$6.92
$457.09M - 52 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$3.58
$237.15M 5.9 53 Compare
BIOA BioAge Labs, Inc. Common Stock
$17.66
$212.23M - 52 Compare
MGNX MacroGenics, Inc.
$4.25
$107.45M - 60 Compare

Data updated: May 18, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

48 stocks in this industry